Bupivacaine Liposomes(BL)

Phase 3Small molecule

HHuazhong University of Science and Technology

Bupivacaine Liposomes(BL) is one of 8 small molecule programs targeting Bupivacaine. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BupivacaineRecruiting

BupivacainePhase 3

Recruiting

Competition

Competitive Landscape

14 competitors in Bupivacaine

#DrugCompanyPhaseTrials

Marcaine

IInnocoll

Approved

29 2

EXPAREL

Pacira Pharmaceuticals, Inc

Phase 3

3 3

Bupivacain

IIstanbul University

Phase 2

3 4

Ketalar

AAultman Health Foundation

Phase 1

3 5

AMPHADASE

AAntares Pharma Inc.

Phase 1

1 6

Bupivacaine Liposomes(BL)

HHuazhong University of Science and Technology

Phase 3

1 7

Ophthaine

VVitae Pharmaceuticals Inc., an Allergan affiliate

Preclinical

1 8

Warm Bupivacaine

MMansoura University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

ApprovedRecruiting

Bupivacaine

NCT06737341

Clinical

Trials by Indication[1]

Interscalene Brachial Plexus Block1 trial

Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

Enrolling by invitation·—··NCT06972680·60 enrolled

Bupivacaine1 trial

Effect of Bupivacaine Liposomes or Bupivacaine for Ultrasound-guided CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery: a Prospective, Single Blind, Completely Randomized, Active Controlled Clinical Trial

Recruiting·HHuazhong University of Science and Technology·Approved·NCT06737341·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Bupivacaine Liposomes(BL). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bupivacaine Liposomes(BL) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bupivacaine Liposomes(BL). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Huazhong University of Science and Technology company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: HHuazhong University of Science and Technology

Bupivacaine Liposomes(BL)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Interscalene Brachial Plexus Block1 trial

Bupivacaine1 trial

References

Drug Info

Quick Facts

Related News